Share This Page
Patent: 10,336,793
✉ Email this page to a colleague
Summary for Patent: 10,336,793
Title: | Flagellin-based agents and uses including effective vaccination |
Abstract: | The present invention relates to, in part, compositions comprising improved flagellin derived constructs and methods of using for vaccination, including adjuvants comprising flagellin-based agents. |
Inventor(s): | Gudkov; Andrei V. (Buffalo, NY), Mett; Vadim (Buffalo, NY), Krivokrysenko; Vadim (Buffalo, NY) |
Assignee: | GENOME PROTECTION, INC. (Buffalo, NY) |
Application Number: | 15/500,133 |
Patent Claims: | see list of patent claims |
Patent landscape, scope, and claims summary: | Analyzing the Claims and Patent Landscape of United States Patent 10,336,793 IntroductionUnited States Patent 10,336,793, titled "Flagellin-based agents and uses including effective vaccination," presents a significant innovation in the field of immunology and vaccine development. This patent, like any other, is subject to a thorough analysis of its claims and the broader patent landscape to understand its implications, strengths, and potential challenges. Overview of the PatentThe patent in question involves compositions and methods using improved flagellin-derived constructs for vaccination and other therapeutic applications. Flagellin, a protein component of bacterial flagella, is known for its potent immune-stimulating properties, making it a valuable component in vaccine development. Claims AnalysisIndependent ClaimsThe independent claims of a patent are crucial as they define the scope of the invention. For US Patent 10,336,793, the independent claims typically outline the specific compositions, methods of preparation, and uses of the flagellin-based agents.
Dependent ClaimsDependent claims further specify the invention and often provide additional details that narrow down the scope of the independent claims.
Patent LandscapePrior ArtUnderstanding the prior art in the field of flagellin-based vaccines is essential to assess the novelty and non-obviousness of the patented invention.
Competing PatentsThe patent landscape includes other patents that may cover similar or related inventions. Analyzing these competing patents can help in understanding the competitive environment.
Licensing and LitigationThe patent landscape also involves potential licensing agreements and litigation risks.
Industry ImpactMarket PotentialThe market potential of a patent is closely tied to its claims and the broader patent landscape.
Expert InsightsIndustry experts often provide valuable insights into the strengths and weaknesses of a patent.
Statistical AnalysisStatistical analysis can provide quantitative insights into the patent's strength and impact.
Field ApplicationsThe practical applications of the patent are a key aspect of its analysis.
Challenges and LimitationsNovelty and Non-ObviousnessEnsuring that the patent meets the criteria of novelty and non-obviousness is critical.
EnforcementThe enforceability of the patent is another crucial aspect.
Key Takeaways
FAQsQ: What is the main focus of United States Patent 10,336,793? A: The main focus of this patent is on compositions and methods using improved flagellin-derived constructs for vaccination and other therapeutic applications. Q: Why are clear and specific claims important in a patent? A: Clear and specific claims are important because they ensure strong protection and enforceability of the patent, reducing the risk of disputes and litigation. Q: How does the patent landscape impact the value of a patent? A: The patent landscape, including prior art, competing patents, and licensing opportunities, significantly impacts the value of a patent by defining its competitive position and market potential. Q: What role does regulatory approval play in the commercial success of a patent? A: Regulatory approval is crucial for the commercial success of a patent, especially in the pharmaceutical and biotechnology sectors, as it ensures that the patented invention meets the necessary safety and efficacy standards. Q: How can statistical analysis help in evaluating a patent? A: Statistical analysis, such as examining claim length and count, can provide insights into the patent's strength and impact, including its probability of grant and examination process duration. Sources
More… ↓ |
Details for Patent 10,336,793
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bavarian Nordic A/s | RABAVERT | rabies vaccine | For Injection | 103334 | October 20, 1997 | 10,336,793 | 2034-07-30 |
Sanofi Pasteur Sa | IMOVAX RABIES | rabies vaccine | For Injection | 103931 | February 04, 2000 | 10,336,793 | 2034-07-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |